Validity of the activPAL3 activity monitor in people moderately affected by Multiple Sclerosis
dc.contributor.author | Coulter, EH | |
dc.contributor.author | Miller, L | |
dc.contributor.author | McCorkell, S | |
dc.contributor.author | McGuire, C | |
dc.contributor.author | Algie, K | |
dc.contributor.author | Freeman, Jennifer | |
dc.contributor.author | Weller, B | |
dc.contributor.author | Mattison, PG | |
dc.contributor.author | McConnachie, A | |
dc.contributor.author | Wu, O | |
dc.contributor.author | Paul, L | |
dc.date.accessioned | 2017-05-26T11:18:50Z | |
dc.date.available | 2017-05-26T11:18:50Z | |
dc.date.issued | 2017-07 | |
dc.identifier.issn | 1350-4533 | |
dc.identifier.issn | 1873-4030 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/9362 | |
dc.description.abstract |
Walking is the primary form of physical activity performed by people with Multiple Sclerosis (MS), therefore it is important to ensure the validity of tools employed to measure walking activity. The aim of this study was to assess the criterion validity of the activPAL3 activity monitor during overground walking in people with MS. Validity of the activPAL3 accelerometer was compared to video observation in 20 people moderately affected by MS. Participants walked 20-30m twice along a straight quiet corridor at a comfortable speed. Inter-rater reliability of video observations was excellent (all intraclass correlations >0.99). The mean difference (activPAL3- mean of raters) was -4.70±9.09, -4.55s±10.76 and 1.11s±1.11 for steps taken, walking duration and upright duration respectively. These differences represented 8.7%, 10.0% and 1.8% of the mean for each measure respectively. The activPAL3 tended to underestimate steps taken and walking duration in those who walked at cadences of ≤38 steps/min by 60% and 47%, respectively. The activPAL3 is valid for measuring walking activity in people moderately affected by MS. It is accurate for upright duration regardless of cadence. In participants with slow walking cadences, outcomes of steps taken and walking duration should be interpreted with caution. | |
dc.format.extent | 78-82 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | Elsevier BV | |
dc.subject | Validity | |
dc.subject | Accelerometer | |
dc.subject | Measurement | |
dc.subject | Multiple Sclerosis | |
dc.subject | Physical activity | |
dc.title | Validity of the activPAL3 activity monitor in people moderately affected by Multiple Sclerosis | |
dc.type | journal-article | |
dc.type | Journal Article | |
dc.type | Validation Study | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000403625100009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.volume | 45 | |
plymouth.publication-status | Published | |
plymouth.journal | Medical Engineering & Physics | |
dc.identifier.doi | 10.1016/j.medengphy.2017.03.008 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/School of Health Professions | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Health and Community | |
plymouth.organisational-group | /Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR) | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
plymouth.organisational-group | /Plymouth/Users by role/Researchers in ResearchFish submission | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2017-03-26 | |
dc.rights.embargodate | 2018-4-10 | |
dc.identifier.eissn | 1873-4030 | |
dc.rights.embargoperiod | 12 months | |
rioxxterms.versionofrecord | 10.1016/j.medengphy.2017.03.008 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
rioxxterms.licenseref.startdate | 2017-07 | |
rioxxterms.type | Journal Article/Review |